10 April 2015

Ellex to Host Canaloplasty and Vitreolysis Symposia at ASCRS 2015

Adelaide, Australia, 14 April 2015 – Ellex Medical (Adelaide, Australia) will host two symposia featuring world-renowned experts in Canaloplasty and Laser Vitreolysis at the 2015 meeting of the American Society of Cataract and Refractive Surgery in San Diageo, USA from April 17-21.

Canaloplasty for Glaucoma
The first event, a Canaloplasty symposium, will be held on Monday, 20 April at the Marriott Marquis (Point Loma) from 6:15 am – 7:30 am. The panel of speakers will include Associate Professor, Mahmoud A Khaimi, Dean McKee Eye Institute, University of Oklahoma, USA, Mark Gallardo, MD, El Paso Eye Surgeons, Texas, USA and David Richardson, MD, San Marino Eye, California, USA. The panel will be sharing the latest developments in the treatment of glaucoma including Ab-interno Canaloplasty, a new approach to minimally-invasive glaucoma surgery (MIGS), which employs the proven 360 degree visco-dilation impact of traditional Canaloplasty in an ab-interno approach to Schlemm’s Canal. Ab-interno Canaloplasty is more comprehensive than traditional MIGS techniques due to its ability to access, catheterize and viscodilate all aspects of outflow resistance. Preliminary findings from a 70-eye case series showed that the mean intraocular pressure (IOP) was reduced from 20.3±5.8 mm Hg to 12.3±6.8 at 6 months postoperative. The mean number of medications was also reduced – from 2.4±0.9 to 0.5±1.0.

Drs Gallardo, Richardson, and Khaimi will also join Susan Senft, MD, Island Eye Care, Hawaii, USA, at a series of “Meet the Expert” sessions being held at the Ellex Exhibit (#815), in which they will share their pearls for success with Canaloplasty. The one-hour Meet the Expert sessions will be held on Saturday, 18 (10 am – 12 pm; 2 pm – 4 pm), Sunday 19 (11 am – 12pm; 2pm – 3 pm) and Monday 20 April (11 am – 12pm; 2pm – 3 pm).

Laser Vitreolysis for Floaters
Ellex is also hosting a breakfast symposium on laser vitreolysis at the Marriott Marquis (Point Loma/Solana) on Sunday 19 April from 6:30 am – 7:30 am in which Paul Singh, MD, The Eye Center of Kenosha, Wisconsin, USA, will be sharing his step-by-step approach to the treatment of vitreous strands and opacities.

Although considered benign, bothersome vitreous strands or “floaters” are known to have a significant impact on the functioning and quality of life of some patients. By providing a viable and safe treatment option, laser vitreolysis provides an opportunity to enhance patient satisfaction as well as scope of practice.

During the symposium, Dr Singh will share findings from a retrospective, observational study of 296 eyes (of 198 patients), showing that 93% of patients were satisfied with outcomes following laser vitreolysis with the Ultra Q Reflex™ laser system from Ellex.

“Of all the treatments I offer, laser vitreolysis has, hands down, had the biggest impact. Having performed well over 650 laser vitreolysis procedures, I can attest that the effect on patients’ quality of life is remarkable,” says Dr Singh.

Dr Singh will also be available to discuss his experience with laser vitreolysis and share his surgical tips at two “Meet the Expert” sessions being held at the Ellex Exhibit (#815) on Saturday 18 and Sunday 19, April from 11:00 am – 12 pm. He will also be available for interviews with the media.


Ellex Medical (Ellex) is a pioneer in the development of medical technologies for the diagnosis and treatment of eye disease. With more than 20,000 systems delivered to market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States, Japan, France, Germany and Australia, and a network of distribution partners in more than 100 countries. In recent years, Ellex has diversified its product range beyond lasers and ultrasound equipment to include distribution of a number of complementary third-party ophthalmic products. On 31 December 2013 Ellex acquired the Canaloplasty microcatheterbased glaucoma surgical treatment from iScience Interventional, Inc.

For additional information about Ellex and its products, please visit www.ellex.com